IP Verse

Kraus & Lederer patent opposition analysis

The comprehensive analysis of Kraus & Lederer opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kraus & Lederer

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3432729	Nanocapsules Comprising A Liposoluble Active Ingredient, Production And Uses	ADISSEO FRANCE	May 12, 2026	DSM NUTRITIONAL PRODUCTS
EP3689365	Use Of Long-Acting Glp-1 Peptides	NOVO NORDISK	Mar 24, 2026	KRAUS & LEDERER PARTGMBB
EP4316598	Pharmaceutical Composition Containing Poorly-Soluble Basic Medicine	CHUGAI SEIYAKU KABUSHIKI KAISHA	Mar 18, 2026	TEVA PHARMACEUTICAL INDUSTRIES
EP4370650	Method For Isolating Proteins And Saccharides From Yeast	YEASTUP	Jan 15, 2026	KRAUS & LEDERER
EP3592732	Manufacture Of A Crystalline Pharmaceutical Product	ORION	Jan 8, 2026	KRAUS & LEDERER
EP3256113	Treatment Of Hypoparathyroidism	ENTERA BIO	Dec 29, 2025	KRAUS & LEDERER
EP3470400	Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method Therefor	CRYSTAL PHARMACEUTICAL SUZHOU	Dec 23, 2025	SANDOZ
EP3802639	Propylene-Ethylene Random Copolymers With Low Xs/Et Ratio And High Mfr	W R GRACE & CONN	Nov 19, 2025	KRAUS & LEDERER
EP3800177	Fenfluramine Compositions And Methods Of Preparing The Same	ZOGENIX	Oct 23, 2025	SANDOZ
EP3539540	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Sep 12, 2025	TEVA PHARMACEUTICALS

Top companies who are the clients of Kraus & Lederer

Company	Total
KRAUS & LEDERER PARTGMBB	68
KRAUS & LEDERER	38
SANDOZ	28
TEVA PHARMACEUTICALS	28
DSM NUTRITIONAL PRODUCTS	18
TEVA PHARMACEUTICAL INDUSTRIES	8
HEXAL	6
DSM ASSETS	5
STADA ARZNEIMITTEL	5
ALFASIGMA	4